Amgen is pushing deeper into cardiovascular medicine as its cholesterol drug Repatha continues to gain ground following a significant regulatory milestone. The US Food and Drug Administration granted Repatha a label expansion
London’s FTSE 100 index has surged to record intraday highs over two consecutive sessions, buoyed by a string of better-than-expected corporate results. The blue-chip index reached a high of 10,979.24 on Thursday,
MoreReddit (NYSE: RDDT) delivered a strong set of financial results for the second quarter of 2026, yet investors responded by sending shares sharply lower. The stock fell approximately 10.3% following the earnings
MoreThe company behind TV chef Gino D’Acampo’s restaurant empire has been hit with a winding-up petition by the UK tax authority. Upmarket Hotels and Leisure, which operates five British restaurants named after
MoreThe US Food and Drug Administration has moved into full enforcement of the Drug Supply Chain Security Act after an 18-month stabilisation grace period concluded. The enforcement shift marks a significant turning
MoreA decades-old California statute is driving a sharp rise in privacy litigation against companies using common website tracking technologies across the United States. The California Invasion of Privacy Act, known as CIPA,
MoreA new Gallup poll has revealed that the US Supreme Court’s approval rating has sunk to a historic low of just 33 percent. This marks the worst approval figure recorded since Gallup
MoreThe U.S. economy expanded at a weaker-than-expected pace in the second quarter, while inflation remained stubbornly above the Federal Reserve’s target, the Commerce Department reported Thursday. Gross domestic product, a broad measure
MoreEmber LifeSciences has entered into a capital and business alliance with Alfresa Corporation to strengthen pharmaceutical cold chain logistics across Japan. Alfresa Corporation is a subsidiary of Alfresa Holdings Corporation, which holds
MoreFintent, a leading intelligence provider for investment banks and corporate law firms, has published its July 2026 manufacturing deal predictions, revealing how its system flagged transactions long before they went public. The
MoreThe rapid expansion of AI tools across the legal industry has largely bypassed one of its most critical sectors: criminal defense, where resources are thin and needs are urgent. Legal technology vendors
More
